L

Longwood Capital Partners LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Longwood Capital Partners LLC with $96.8M in long positions as of Q3 2025, 86% allocated to Healthcare, and 76% concentrated in top 10 positions.

Portfolio Value
$96.8M
Top 10 Concentration
76%
Top Sector
Healthcare (86%)
US Exposure
88%
Market Cap Focus
Small Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 85.90%Healthcare
Healthcare
85.90%

Industry Breakdown

1 industry across all sectors

Biotechnology: 85.94%Biotechnology
Biotechnology
Healthcare
85.94%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 6.74%Mid Cap ($2B - $10B): 35.36%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 41.66%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 9.34%Micro Cap ($50M - $300M)N/A (ETF or Unknown): 6.89%
Large Cap ($10B - $200B)
6.74%
Mid Cap ($2B - $10B)
35.36%
Small Cap ($300M - $2B)
41.66%
Micro Cap ($50M - $300M)
9.34%
N/A (ETF or Unknown)
6.89%

Portfolio Concentration

Top 10 Holdings %
75.97%
Top 20 Holdings %
95.69%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
88.0%
International
12.0%
Countries
4
Largest Int'l Market
Canada - 6.73%
United States of America
88.00% ($85.2M)
24 holdings
Canada
6.73% ($6.5M)
2 holdings
Ireland
3.42% ($3.3M)
1 holdings
Switzerland
1.85% ($1.8M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
5.4 quarters
Avg. Top 20
4.2 quarters
Avg. All Positions
3.8 quarters
Median Holding Period
2.5 quarters
Persistence Rate
39.29%
Persistent Holdings Weight
48.82%
Persistent Positions
11
Longest Held
Terns Pharmaceuticals, Inc. Common Stock logo
Terns Pharmaceuticals, Inc. Common StockTERN - 12 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
1.96%
Avg. Position Weight
3.57%
Largest Position
Ocular Therapeutix, Inc. logo
Ocular Therapeutix, Inc.OCUL - 14.08%
Largest Ownership Stake
WHWK
Whitehawk Therapeutics, Inc. Common StockWHWK - 7.24%
Avg. Ownership Stake
0.99%
Ownership Stake >5%
1
Ownership Stake >1%
4

Historical (Since Q4 2014)

Avg. New Position
2.41%
Avg. Ownership Stake
1.70%
Largest Position
Iovance Biotherapeutics, Inc. Common Stock logo
Iovance Biotherapeutics, Inc. Common StockIOVA - 43.45% (Q4 2018)
Largest Ownership Stake
Iridex Corp logo
Iridex CorpIRIX - 12.61% (Q4 2017)

Portfolio Turnover

Current Quarter

Turnover Ratio
22.1%
Value Traded
$21.34M
Positions Added
5
Positions Exited
8

Historical (Since Q4 2014)

Avg. Turnover Ratio
27.7%
Avg. Positions Added
10
Avg. Positions Exited
11
Highest Turnover
50.0%
Q4 2014
Lowest Turnover
10.1%
Q1 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.